Cetrelimab, CAS [[2050478-92-5]]

Produktübersicht

• Artikelname: Cetrelimab, CAS [[2050478-92-5]]
• Artikelnummer: TGM-T76945
• Hersteller Artikelnummer: T76945
• Alternativnummer: TGM-T76945-1MG,TGM-T76945-5MG,TGM-T76945-10MG,TGM-T76945-25MG,TGM-T76945-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: JNJ 63723283 , JNJ3283 , JNJ 3283 , JNJ63723283

Produktbeschreibung

Cetrelimab (JNJ 63723283) is a humanized anti-PD-1 monoclonal antibody that dose-dependently increases T cell-mediated cytokine production and stimulates cytokine expression. It is used in multiple myeloma and bladder cancer research.

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [2050478-92-5]
• Target-Kategorie: Interleukin|||PD-1/PD-L1|||TNF